Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ambispective Cohort Study on the Correlation Between 4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) Promoter and Moderate to Severe Postoperative Acute Renal Injury in Patients With Aortic Dissection

NCT05490394 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05490394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05490394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ambispective Cohort Study on the Correlation Between 4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) Promoter and Moderate to Severe Postoperative Acute Renal Injury in Patients With Aortic Dissection
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Completed
Start date
April 28, 2022
Completion date
August 1, 2022
Enrollment
283 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aki - acute kidney injury, aortic dissection, pai-1 4g/5g polymorphism